Načítá se...
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
The epidermal growth factor receptor (EGFR) is a therapeutic target in patients with various cancers. Unfortunately, resistance to EGFR-targeted therapeutics is common. Previous studies identified two mechanisms of resistance to the EGFR monoclonal antibody cetuximab: Nuclear translocation of EGFR b...
Uloženo v:
| Vydáno v: | Sci Signal |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7094775/ https://ncbi.nlm.nih.gov/pubmed/28049763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aag1064 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|